A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair

Publication/Presentation Date

4-2016

Volume

86

Issue

16

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article

Share

COinS